Professor Hisham Mehanna
InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham
Professor Mehanna is the Chair of Head and Neck Surgery, and Director of InHANSE, at the University of Birmingham.
Hisham’s clinical interests are recurrence head and neck cancer surgery and thyroid and minimal access parathyroid surgery.
Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £10million in research grants. The main areas of his research are Human Papillomavirus-associated head and neck cancer and thyroid cancer. His research themes are drug development and redeployment, biomarkers of treatment response and early and late phase clinical trials in head and neck cancer. He is chief investigator of several multicentre and multinational clinical trials, including the PET NECK trial, published in the NEJM in 2016.
He is currently President of the British Association of Head Neck Oncologists (BAHNO) and past Chair of the Research Committee of BAHNO, the UK’s multi-disciplinary professional body, and past Chair of the UK’s National Cancer Research Institute’s head and neck group, responsible for all head neck cancer research in the UK.
Clinical trials that change patient care and the lessons learnt
EVEN MORE SEMINARS
Sanjay P Prabhu Boston Children’s Hospital & Harvard Medical School
Evolving role of machine learning in brain tumour imaging
Professor David Maintz University Hospital Cologne, Department of Radiology
Spectral CT: Dual layer technology helps to increase diagnostic confidence
Dr Ioanna Nixon Beatson West of Scotland Cancer center, NHS Greater Glasgow and Clyde
When the oncologist meets the patient: value of compassion. How well are we doing?
Nizar Asadi Royal Brompton & Harefield NHS Foundation Trust
Thoracic surgery in the treatment of lung cancer
Merina Ahmed Royal Marsden NHS foundation Trust
Stereotactic Radiotherapy for lung tumours and oligometastatic disease